期刊
JOURNAL OF IMMUNOLOGY
卷 193, 期 6, 页码 2821-2830出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1302498
关键词
-
类别
资金
- National Institutes of Health [CA164062, AI053825, CA155823, AI 091965]
- National Institutes of Health Institutional Postdoctoral Training Award [AI049823]
- University of Vermont start-up funding
- Trudeau Institute
TLR-mediated activation of dendritic cells (DCs) is associated with a metabolic transition in which mitochondrial oxidative phosphorylation is inhibited by endogenously synthesized NO and the cells become committed to glucose and aerobic glycolysis for survival. We show that inhibition of mechanistic target of rapamycin (mTOR) extends the lifespan of TLR-activated DCs by inhibiting the induction of NO production, thereby allowing the cells to continue to use their mitochondria to generate ATP, and allowing them the flexibility to use fatty acids or glucose as nutrients to fuel core metabolism. These data provide novel mechanistic insights into how mTOR modulates DC metabolism and cellular longevity following TLR activation and provide an explanation for previous findings that mTOR inhibition enhances the efficacy of DCs in autologous vaccination.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据